Predict your next investment

River Diagnostics company logo
HEALTHCARE | Medical Devices & Equipment / Surgical Devices
riverd.com

See what CB Insights has to offer

Founded Year

2002

Stage

Series A | Alive

About River Diagnostics

River Diagnostics is dedicated to the development of products for the healthcare and medical research marketplace based on the vast potential of non-invasive/non-destructive Raman spectroscopy. Today researchers in personal care, and dermatological research are using River Diagnostics' instruments to understand the metabolic processes in the skin, and other fundamental research questions.

River Diagnostics Headquarter Location

Dr. Molewaterplein 50

Ee 1979 3015 GE,

Netherlands

Latest River Diagnostics News

TechFund co-leads series "A financing round" of River Diagnostics Holding

Jul 19, 2013

Soest, November 28, 2007 TechFund announced today the closure of the Series "A financing round". The round was co-led by The Erasmus MC Biomedical Fund and TechFund. River Diagnostics develops and brings to market medical diagnostic instruments which make use of an optical technology named Raman spectroscopy. Recently, the company unveiled its technology for easy and rapid identification of bacteria at strain level, which will be a crucial tool in the fight against hospital acquired infections. It will enable infection prevention teams to monitor transmission and spreading of bacteria in hospitals and will provide early warnings in case of contaminations and potential outbreaks, caused by well known “hospital bugs”, such as MRSA. The company’s other line of business focuses on the field of dermatology. Its Skin Composition Analyzer provides detailed information about skin composition and about the penetration and effects of topically applied products. Gerwin Puppels, CEO at River Diagnostics: “We are very pleased with the closure of this financing round and with two experienced venture capital investors like the Erasmus MC Biomedical Fund and TechFund participating in the success of our company. The financing will enable River Diagnostics to launch its microorganism identification device and to further develop its other lines of business.”   “We are excited to be making this investment in River Diagnostics” says Tom Schwarz, partner at the Erasmus MC Biomedical Fund. “The company’s microorganism identification device beats the golden standard not only by identifying microorganisms real-time at strain level, but also by doing so in a rapid, high-throughput manner of 100 samples per hour after an overnight culturing step. Given the knowledge of the company’s scientific team, it is obvious that many more applications will be developed and commercialized by River Diagnostics in the coming years. I am looking forward to working closely with the management team as a new member of the company’s Supervisory Board.”   About River Diagnostics (www.riverd.com) River Diagnostics develops and brings innovative solutions for clinical diagnostics and life sciences R&D to market, based on the vast potential of Raman spectroscopy for cell and tissue characterization. River Diagnostics addresses unmet needs and untapped markets in clinical diagnostics and life sciences R&D with products and services based on Raman spectroscopy; an optical technology, which enables detailed analysis of cells and tissues. The company was founded as a spin-out of the Center for Optical Diagnostics and Therapy of the Erasmus-university Medical Center in Rotterdam, The Netherlands, with which it continues to maintain a close working relationship. About TechFund B.V. (www.tiin.net) Based in Soest, TechFund B.V. invests in ICT, Nano and Medical technology. TechFund is founded by TIIN (The Informal Investors Network BV) and Atlantic Capital B.V. and funded by a group of 35 business angels. TechFund is cofunded by TechnoPartner, a Dutch agency supported by the Department of Economic Affairs that provided seed funds. For more information, please visit www.tiin.net and www.atlanticcapital.nl About the Erasmus MC Biomedical Fund (www.erasmusmcfund.nl) The Erasmus MC Biomedical Fund is an independent venture capital fund focusing on early stage companies and (university) spin-outs in the biotechnology and biomedical field with a presence in the Rotterdam region. The fund targets companies that are developing commercially promising products and technologies in life sciences, including pharmaceuticals, biotechnology, information technology and other high technology opportunities that offer venture capital returns. For further information please contact: Willem van den Berg

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

River Diagnostics Patents

River Diagnostics has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/17/2008

11/24/2015

Spectroscopy, Epidemiological study projects, Epidemiology, Infectious diseases, Cohort studies

Grant

Application Date

7/17/2008

Grant Date

11/24/2015

Title

Related Topics

Spectroscopy, Epidemiological study projects, Epidemiology, Infectious diseases, Cohort studies

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.